Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Clinical trial NCT05216835 · COMPLETED
Trial details
- NCT number
- NCT05216835
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-18
- Primary completion
- 2024-08-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.